Here is a site that may be of interest to those who have been diagnosed with Type 1 Diabetes
What is Type 1 Diabetes TrialNet?
Type 1 Diabetes TrialNet is an international network of researchers who are exploring ways to prevent, delay and reverse the progression of type 1 diabetes.
TrialNet was established in response to the Surgeon General's Report Healthy People 2010.
This report identified diabetes as a national health objective for the Nation. In response to the report, Congress created the Diabetes Research Working Group (DRWG) to develop a plan for diabetes research. One recommendation of the DRWG was to conduct additional research studies (clinical trials) to prevent type 1 diabetes.
TrialNet is jointly funded by:
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The National Institute of Allergy and Infectious Diseases (NIAID)
The National Institute of Child Health and Human Development (NICHD)
The National Center for Research Resources at the NIH, which provides support through its General Clinical Research Centers (GCRC) Program.
Juvenile Diabetes Research Foundation International (JDRF).
American Diabetes Association (ADA)
TrialNet is conducting clinical trials with researchers from 18 Clinical Centers in the United States, Canada, Finland, United Kingdom, Italy, Germany, Australia and New Zealand.
In addition, more than 150 medical centers and physician offices are participating in the TrialNet network.
Studies are available for people newly diagnosed with type 1 diabetes, as well as for relatives of people with type 1 diabetes who are at greater risk of developing the disease.
Click the link below for more information:
Next Discussion: French Fries »